Saurabh Satija Selected Research

Respiratory Tract Diseases (Respiratory Tract Disease)

1/2022	Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.
10/2021	Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases.
2/2021	Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities.
1/2021	Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation.
1/2021	Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
1/2020	Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier Based Drug Delivery Systems.
1/2020	Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases.
1/2020	Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases.
8/2019	Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
1/2019	The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saurabh Satija Research Topics

Disease

14	Neoplasms (Cancer) 03/2022 - 08/2012
10	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2019
5	Inflammation (Inflammations) 01/2022 - 02/2019
5	Lung Neoplasms (Lung Cancer) 11/2020 - 05/2019
5	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 01/2019
4	COVID-19 01/2021 - 01/2020
4	Infections 01/2020 - 01/2019
3	Asthma (Bronchial Asthma) 07/2020 - 08/2019
2	Airway Remodeling 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 01/2021 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 11/2020 - 01/2020
2	Lung Diseases (Lung Disease) 08/2020 - 05/2020
2	Cystic Fibrosis (Mucoviscidosis) 07/2020 - 01/2020
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 05/2019
1	Fibrosis (Cirrhosis) 03/2022
1	Liver Neoplasms (Liver Cancer) 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Cognitive Dysfunction 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Epilepsy (Aura) 03/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Polyps 01/2020
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2019
1	Colitis 12/2019
1	Disease Progression 12/2019

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2020
3	Liposomes (Liposome)IBA 01/2020 - 11/2018
2	Plant ExtractsIBA 03/2022 - 01/2020
2	CurcuminIBA 03/2022 - 01/2021
2	LipidsIBA 01/2022 - 11/2020
2	InterleukinsIBA 10/2021 - 11/2020
2	Oxidants (Oxidizing Agents)IBA 10/2021 - 01/2021
2	CytokinesIBA 10/2021 - 05/2019
2	Biological ProductsIBA 02/2021 - 01/2019
2	VaccinesIBA 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	AlbuminsIBA 11/2020 - 01/2020
2	3,3',4,5'-tetrahydroxystilbeneIBA 11/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 11/2020 - 01/2019
2	PolymersIBA 11/2020 - 09/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Dendrimers (Dendrons)IBA 05/2019 - 11/2018
2	EnzymesIBA 02/2019 - 01/2019
2	AntioxidantsIBA 02/2019 - 08/2012
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Aluminum ChlorideIBA 01/2022
1	Donepezil (Aricept)FDA LinkGeneric 01/2022
1	Bromelains (Bromelain)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	ChemokinesIBA 10/2021
1	Dronabinol (THC)FDA LinkGeneric 03/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2021
1	CannabidiolIBA 03/2021
1	FluorocarbonsIBA 01/2021
1	AntagomirsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Rutin (Rutoside)IBA 01/2021
1	AntigensIBA 11/2020
1	Monoclonal AntibodiesIBA 11/2020
1	ChitosanIBA 11/2020
1	boswellic acidIBA 11/2020
1	secukinumabIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	Peptide Hydrolases (Proteases)FDA Link 07/2020
1	naringeninIBA 07/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Interferon beta-1a FDA Link 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Carotenoids (Carotene)IBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	InterferonsIBA 01/2020
1	crocinIBA 01/2020
1	Lopinavir FDA Link 01/2020
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2019

Therapy/Procedure

15	Therapeutics 01/2022 - 02/2019
3	Microspheres (Microsphere) 01/2020 - 11/2018
2	Precision Medicine 09/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 09/2020 - 08/2019
1	Immunotherapy 01/2021